Copyright: ©Author(s) 2026.
World J Stem Cells. Sep 26, 2026; 18(9): 121744
Published online Sep 26, 2026. doi: 10.4252/wjsc.121744
Published online Sep 26, 2026. doi: 10.4252/wjsc.121744
Figure 6 Effect of estrogen receptor 1 downregulation on cell stemness and ferroptosis in A2780 cells by inhibiting the Ras homolog gene family member A/Rho-associated coiled-coil containing protein kinase signaling pathway.
A2780 cells were transfected with si-NC and si-ESR1, and treated with CN03. A: Aldehyde dehydrogenas activity significantly decreased in A2780 cells post si-ESR1 transfection, which was partially restored by CN03 treatment; B: Cell spheroidization assay demonstrated a decrease in cell stemness in the si-ESR1 group, with a reversal observed upon CN03 introduction; C: Protein levels of octamer-binding transcription factor 4 and Nanog decreased significantly in the si-ESR1 group, but were restored by CN03 treatment; D: Fe2+ content in A2780 cells increased following si-ESR1 transfection, and decreased with CN03 supplementation; E: Expression levels of ferritin heavy chain and ferritin light chain increased, while transferrin receptor 1 expression decreased in the si-ESR1 group, and these changes were reversed by CN03 treatment. Data was expressed as mean ± SD (n = 3). bP < 0.01 vs si-NC group; dP < 0.01 vs si-ESR1 group. ALDH: Aldehyde dehydrogenas; ESR1: Estrogen receptor 1; OCT4: Octamer-binding transcription factor 4; FTH: Ferritin heavy chain; FTL: Ferritin light chain; TFR1: Transferrin receptor 1.
- Citation: Zhou S, Cheng X, Zhang JM, Ji J, Ni ZZ, Wang W. Estrogen receptor 1 regulates ovarian cancer cell stemness and ferroptosis through modulation of the canonical RhoA/ROCK signaling pathway. World J Stem Cells 2026; 18(9): 121744
- URL: https://www.wjgnet.com/1948-0210/full/v18/i9/121744.htm
- DOI: https://dx.doi.org/10.4252/wjsc.121744